Complement-Based Drug Development Summit leaderboard
  • Monday, August 24, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 208

Author

Pharma Journalist 9017 posts 0 comments

Tonix Pharmaceuticals Announces Acquisition of Preclinical Infectious Disease Portfolio from Healion…

Feb 2, 2023
Tonix Pharmaceuticals Holding Corp. announced an agreement whereby Tonix has acquired all of the assets of Healion Bio, Inc. (Healion) including its entire portfolio of next-generation…
Read More...

Karuna Therapeutics Announces Exclusive Global License Agreement for Goldfinch Bio’s Investigational…

Feb 2, 2023
Karuna Therapeutics, Inc. and GFB (ABC), LLC, assignee of the Goldfinch Bio assignment estate, announced their entry into an exclusive license agreement under which Karuna will obtain…
Read More...

4D Molecular Therapeutics Announces FDA Clearance of IND Application for 4D-150 Genetic Medicine for…

Feb 2, 2023
4D Molecular Therapeutics, a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines, announced FDA clearance of the…
Read More...

Ellipses Pharma Announces FDA Approval of IND Application for EP0042 for Patients With Acute Myeloid…

Feb 2, 2023
Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an innovative drug development model,…
Read More...

Jesduvroq (daprodustat) approved by US FDA for anaemia of chronic kidney disease in adults on…

Feb 2, 2023
GSK plc announced that the US Food and Drug Administration (FDA) has approved Jesduvroq (daprodustat), an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the…
Read More...

MD Anderson and Federation Bio Announce Collaboration to Develop Novel Microbiome Treatment for…

Feb 2, 2023
The University of Texas MD Anderson Cancer Center and Federation Bio, a biotechnology company pioneering bacterial cell therapies, announced a strategic collaboration to design and…
Read More...

Cidara Therapeutics and WuXi XDC Expand Collaboration for IND-enabling CMC Development to Advance…

Feb 1, 2023
Cidara Therapeutics, Inc. and WuXi XDC announced an expansion of their existing collaboration under which WuXi XDC will provide investigational new drug (IND)-enabling chemistry,…
Read More...

Benlysta granted Orphan Drug Designation by US FDA for the potential treatment of systemic sclerosis

Feb 1, 2023
GSK plc announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Benlysta (belimumab), a B-cell inhibiting monoclonal antibody, for the…
Read More...

Cybin Announces Approval of First-in-Human Dosing of its Proprietary DMT Molecule CYB004

Feb 1, 2023
Cybin Inc., a biopharmaceutical company focused on progressing Psychedelics to Therapeutics is pleased to announce that it has received approval from an independent ethics committee in…
Read More...

Daewoong enters exclusive licensing agreement with CS Pharmaceuticals for Bersiporocin in Idiopathic…

Feb 1, 2023
Daewoong Pharmaceutical(CEO Seng-ho Jeon and Chang-jae Lee) has secured an exclusive licensing agreement with CS Pharmaceuticals ("CSP"), a UK based multinational company focused on the…
Read More...
Prev Next
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Piramal Pharma Takes Majority Stake in Yapan Bio
  • Charles River and Medigen Partner on Next-Generation Enterovirus Vaccine
  • WellSpan and Johns Hopkins Expand Cancer Care Collaboration
  • SandboxAQ Launches AI Model to Speed Drug Discovery
  • FDA Approves Ultragenyx Gene Therapy for Rare GSDIa Disorder

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.